RBP7 and colorectal carcinoma: In this study, we identified immune-related genes to 5-FU resistance in the tumor microenvironment and found that RBP7 has the potential to predict chemotherapy resistance and poor prognosis of CRC patients, which will hopefully provide a biomarker for 5-FU resistance and prognosis for CRC patients.